In glioma microenvironment, CD204 is alternatively expressed in TAMs and is correlated with the histological grade and outcome of glioma, suggesting it may serve as an immunotherapeutic target.16 However, the details of CD204 expression and its role in glioma are still unclear. Here, MSR1 is linked to central nervous system cancer.